DigiMed Bayern Symposium 2022

The flagship project DigiMed Bayern demonstrates feasibility of P4-medicinein Bavaria and Germany, from multilayered big data research projects all the way to large scale initiatives preventing atherosclerotic diseases, such as coronary heart disease and stroke. DigiMed Bayern has aruntime from 2018 to 2024 and it is funded with approx. € 25 million bythe Bavarian State Ministry of Health and Care. It generated highly utilized Apps for calculating and minimizing risk of cardiovascular diseases, implemented state-wide measures for preventing atherosclerosisat young age, and produced comprehensive datasets of patients diagnosedwith coronary disease, or with its genetic risk factors. The data are enriched by state-of-the-art multi-dimensional characterization (-omics technologies) for gaining new insights into the molecular mechanisms leading to the diseases. For the integrative analysis of the resulting “Big Data”, a compliant, secure and sustainable IT-infrastructure is fundamentally designed and implemented. Finally, as we will show, patients and persons at risk do and will further benefit from advancements in disease risk prediction, diagnosis, targeted prevention and treatment.

Präsentation von TEAM-X in Session B (12:45-14:05) durch Prof. Bjoern Eskofier

Programm und Registrierung:

https://www.digimed-bayern.de/symposium-2022.html